Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran F Moghaddam

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Bioorganic & Medicinal Chemistry Letters|November 22, 2012
Isosteric analogs of lenalidomide and pomalidomide: synthesis and biological activityAlexander L Ruchelman, Hon-Wah Man, Weihong Zhang, et al.
Journal of Medicinal Chemistry|December 13, 2021
Discovery of the c-Jun N-Terminal Kinase Inhibitor <b>CC-90001</b>Mark A Nagy, Robert Hilgraf, Deborah S Mortensen, et al.
Journal of Medicinal Chemistry|October 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic ScreenJennifer R Riggs, Mark Nagy, Jan Elsner, et al.
Molecular Cancer Therapeutics|April 10, 2015
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo CharacterizationDeborah S Mortensen, Kimberly E Fultz, Shuichan Xu, et al.
Journal of Medicinal Chemistry|June 24, 2015
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, et al.
Journal of Medicinal Chemistry|June 18, 2015
Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Bioorganic & Medicinal Chemistry Letters|November 22, 2012
Isosteric analogs of lenalidomide and pomalidomide: synthesis and biological activityAlexander L Ruchelman, Hon-Wah Man, Weihong Zhang, et al.
Journal of Medicinal Chemistry|December 13, 2021
Discovery of the c-Jun N-Terminal Kinase Inhibitor <b>CC-90001</b>Mark A Nagy, Robert Hilgraf, Deborah S Mortensen, et al.
Journal of Medicinal Chemistry|October 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic ScreenJennifer R Riggs, Mark Nagy, Jan Elsner, et al.
Molecular Cancer Therapeutics|April 10, 2015
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo CharacterizationDeborah S Mortensen, Kimberly E Fultz, Shuichan Xu, et al.
Journal of Medicinal Chemistry|June 24, 2015
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, et al.
Journal of Medicinal Chemistry|June 18, 2015
Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, et al.
Pageof 2